CE15 - Immunologie, Infectiologie et Inflammation 2021

Structure-function analysis of Plasmodium vivax blood stage ligands for invasion – PvINV

Submission summary

Plasmodium vivax causes significant morbidity in the tropical world. A vaccine that protects against P. vivax and reduces transmission would help efforts to eliminate malaria. The P. vivax Duffy binding protein (PvDBP), a leading vaccine candidate, binds the Duffy antigen receptor (DARC) to mediate reticulocyte invasion by P. vivax merozoites. We will determine the structure of the PvDBP-DARC complex and map the binding site for DARC. In addition, we will investigate the potential role of the PvDBP homolog, P. vivax erythrocyte binding protein (PvEBP), in mediating reticulocyte invasion. We will also explore the functional roles of novel P. vivax antigens that are structural homologs of the P. falciparum invasion protein, PfRH5. Finally, we will identify combinations of P. vivax invasion ligands that elicit synergistic invasion inhibitory antibodies as potential vaccine candidates for P. vivax.

Project coordination

Chetan CHITNIS (IP-Biologie de Plasmodium et Vaccins)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partnership

IP-Virologie Structurale IP-Virologie Structurale
IP-Biologie de Plasmodium et Vaccins IP-Biologie de Plasmodium et Vaccins

Help of the ANR 571,751 euros
Beginning and duration of the scientific project: September 2021 - 42 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter